The 2026 programme will include:

– 3 high quality plenary lectures
– 9 sessions on key topics in Medicinal Chemistry
– About 18 oral communications selected from the submitted abstracts
– An extensive social program to maximize your networking opportunities
– A poster session and a commercial exhibition

The meeting attracts a highly targeted audience composed of experts, researchers and early career trainees in drug discovery and development, in particular medicinal and synthetic chemists, together with scientists active in the fields of computer assisted drug design, biology, drug metabolism and pharmacokinetics (DMPK), pharmacology, and early toxicology.

The 2026 edition is chaired by Prof. Marina RUBINI (University College Dublin, Ireland)